Finding Solutions to Thrive After Birth Asphyxia in Africa

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Birth Asphyxia
Interventions
DRUG

Sildenafil

Dose group 1st dose 2nd dose 3rd dose 4-14th doses Treatment Total dose/day frequency dose/day Group 1: #1-14=2 mg/kg q12h (4 mg/kg/day) Group 2: #1 = 2 mg/kg, #2-14 = 2.5 mg/kg q12h (5 mg/kg/day) Group 3: #1 = 2 mg/kg, #2 = 2.5 mg/kg, #3-14 = 3 mg/kg q12h (6 mg/kg/day) Group 4: #1 = 2.5 mg/kg, #2-14 = 3 mg/kg q12h (6 mg/kg/day) Group 5: #1-14 = 3 mg/kg q12h (6 mg/kg/day)

Trial Locations (1)

Unknown

Kawempe National Referral Hospital, Kawempe

All Listed Sponsors
collaborator

Kawempe National Referral Hospital

UNKNOWN

collaborator

Saint Francis Hospital

OTHER

collaborator

Walimu

OTHER

lead

Pia Wintermark

OTHER